Table of Contents
Transcranial magnetic stimulation, also known as TMS, is a remarkably simple, relatively inexpensive, and side effects-free non-invasive method of treating chronic pain. The neuroAD Therapy System by Neuronix Corporation presents a novel method for using transcranial magnetic stimulation for treating mild to moderate Alzheimer's disease.
What Is Transcranial Magnetic Stimulation?
Transcranial magnetic stimulation is a form of magnetic therapy that involves the application of a pulsating magnetic field across the scalp. The kind of magnets used in transcranial magnetic stimulation are nothing like, say, refrigerator magnets, which exert a constant magnetic force. Pulsating magentic Alzheimer's disease treatment helps ions flow both in and out of the cells in the brain, stimulating the flow of oxygen and nutrients into the cell, and pulling carbon dioxide and waste products out.
A Safe Method of Treatment for Alzheimer's Disease
Transcranial magnetic stimulation sometimes produces dramatic, positive results in neurological disease. Sometimes putting on a magnetized headband stops chronic pain dead in its tracks. Sometimes pulsating magnetic therapy stops the tremors of Parkinson's disease, without the need for surgery to implant the device. Magnet therapy is also used for treating insomnia and depression.
The Neuronix system takes magnetic therapy a step further for treating dementia related to Alzheimer's. The treatment program consists of five daily one-hour sessions every week for six weeks in a clinic or outpatient setting. Alzheimer's patients do not have to be in a rest home or hospital to qualify for the treatment. The patient sits in a chair equipped with magnets that deliver focused magnetic fields to specific parts of the brain, in front of a computer screen that presents them with focused "brain exercises" to use that part of the brain. The magnets provide long-term stimulation to that part of the brain, which makes a connection to the cognitive skill presented on the screen.
Neuronix is designed to counteract the signs of dementia such as memory loss, confusion, mood swings, aggression, loss of language, depression, and withdrawal from social connections, and loss of control of bodily functions. Alzheimer's without treatment is invariably a slow process of deterioration that leads to disability in three to five years, requiring the patient to be institutionalized, and death in seven to ten years.
How Well Does NeuroniAD Work?
NeuronixAD is considered a symptomatic treatment. It does not cure Alzheimer's, but it may stop the progression of symptoms. Patients feel better, and their doctors have the impression they are better. However, NeuronixAD is a treatment for mild Alzheimer's.
The research data show that the benefits of the treatment are due to a combination of magnetic therapy and cognitive training exercises. The benefits of six weeks of daily sessions usually last for six to twelve months, and another round of the treatment may keep the patient for another six to twelve months. The treatment is not entirely free of side effects, but none of the Alzheimer's patients in the clinical trial suffered seizures, and only a minority had headache, neck pain, scalp pain, or fatigue.
NeuronixAD is already approved in the European Union. It is commercially available in Israel, Korea, and Hong Kong. In the US, it is still regarded as an "investigational device."